370 Tumor-wide neoantigen-specific T-cells infiltrating mutant IDH1 low-grade gliomas and persisting in peripheral blood allow for personalized TCR-based immunotherapies

• Michael McDermott,
• Michael Martin,
• Hideho Okada,
• Joseph Costello,
• Michael Zhang,
• Tyler Borrman,
• Stefanie Mandl,
• Zheng Pan,
• Darwin Kwok,
• Chibo Hong,
• Cliff Wang,
• Nicholas Stevers,
• Benjamin Yuen,
• Songming Peng,
• Diana Nguyen,
• Stephanie Hilz,
• Joanna Phillips,
• Anny Shai,
• Nancy Ann Oberheim Bush,
• Shawn L Hervey-Jumper

Affiliations

Michael McDermott

1University of California, San Francisco, San Francisco, CA, USA

Michael Martin

1CureVac Netherlands B.V., Amsterdam, Netherlands

Hideho Okada

1University of California, San Francisco, San Francisco, CA, USA

Joseph Costello

1University of California, San Francisco, San Francisco, CA, USA

Michael Zhang

1University of California, San Francisco, San Francisco, CA, USA

Tyler Borrman

2PACT Pharma, South San Francisco, CA, USA

Stefanie Mandl

2PACT Pharma, South San Francisco, CA, USA

Zheng Pan

2PACT Pharma, South San Francisco, CA, USA

Darwin Kwok

1University of California, San Francisco, San Francisco, CA, USA

Chibo Hong

1University of California, San Francisco, San Francisco, CA, USA

Cliff Wang

2PACT Pharma, South San Francisco, CA, USA

Nicholas Stevers

1University of California, San Francisco, San Francisco, CA, USA

Benjamin Yuen

2PACT Pharma, South San Francisco, CA, USA

Songming Peng

2PACT Pharma, South San Francisco, CA, USA

Diana Nguyen

2PACT Pharma, South San Francisco, CA, USA

Stephanie Hilz

3Genentech, San Francisco, CA, USA

Joanna Phillips

1University of California, San Francisco, San Francisco, CA, USA

Anny Shai

1University of California, San Francisco, San Francisco, CA, USA

Nancy Ann Oberheim Bush

1University of California, San Francisco, San Francisco, CA, USA

Shawn L Hervey-Jumper

4Weill Institute for Neurosciences, San Francisco, CA, USA